Novel cardiovascular biomarkers in women with a history of early preeclampsia

Atherosclerosis

Volumn 237, Issue 1, 2014, Pages 117-122

  Drost, José T ^a   Maas, Angela H E M ^b   Holewijn, Suzanne ^b   Joosten, Leo A B ^b   van Eyck, Jim ^a   van der Schouw, Yvonne T ^c   de Graaf, Jacqueline ^b  

^a ISALA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Biomarker; Cardiovascular disease; Endothelial function; Preeclampsia

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PAPPA1 PROTEIN, HUMAN; SELE PROTEIN, HUMAN;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; AGE; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; E-SELECTIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84934882994     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.09.009     Document Type: Article

References (35)

1. Steegers E.A., von Dadelszen P., Duvekot J.J., Pijnenborg R. Preeclampsia. Lancet 2010, 376:631-644.
2. Drost J.T., Maas A.H., van Eyck J., van der Schouw Y.T. Preeclampsia as a female-specific risk factor for chronic hypertension. Maturitas 2010, 67:321-326.
3. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335(7627):974.
4. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366:1797-1803.
5. Wilson B.J., Watson M.S., Prescott G.J., Sunderland S., Campbell D.M., Hannaford P., Smith W.C. Hypertensive disease of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003, 326(7394):845.
6. Mannisto T., Mendola P., Vaarasmaki M., Jarvelin M.R., Hartikainen A.L., Pouta A., Suvanto E. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013, 127:681-690.
7. Lykke J.A., Langhoff-Roos J., Sibai B.M., Funai E.F., Triche E.W., Paidas M.J. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009, 53:944-951.
8. Magnussen E.B., Vatten L.J., Smith G.D., Romundstad P.R. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet. Gynaecol. 2009, 114:961-970.
9. Stekkinger E., Zandstra M., Peeters L.L., Spaanderman M.A. Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome. Obstet. Gynaecol. 2009, 114:1076-1084.
10. Drost J.T., Arpaci G., Ottervanger J.P., de Boer M.J., van Eyck J., van der Schouw Y.T., Maas A.H.E.M. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk Evaluation in FEMales study (PREVFEM). Eur. J. Prev. Cardiol. 2012, 19:1138-1144.
11. Sattar N., Ramsay J., Carwaford L., Cheyne H., Greer I.A. Classic and novel risk factors in women with a history of preeclampsia. Hypertension 2003, 42:39-42.
12. Ostlund E., Al-Nashi M., Hamad R.R., Larsson A., Eriksson M., Bremme K., Kahan T. Normalized endothelial dysfunction but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypert Res. 2013, 10.1038/hr.2013.81.
13. Johnson M.P., Brennecke S.P., East C.E., Dyer T.D., Roten L.T., Proffitt J.M., Melton P.E., Fenstad M.H., Aalto-Viljakainen T., Mäkikallio K., Heinonen S., Kajantie E., Kere J., Laivuori H., Austgulen R., Blangero J., Moses E.K. Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease. Mol. Hum. Reprod. 2013, 19:423-437. FINNPEC Study Group.
14. Blankenberg S., Zeller T., Daarela O., Havulinna A.S., Kee F., Tunstall-Pedoe H., Kuulasmaa K., Yarnell J., Schnabel R.B., Wild P.S., Munzel T.F., Lackner K.J., Tiret L., Rvans A., Salomma V. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, Risk, Genetics, Archiving, and Monigraph (MORGAM) Biomarker Project. Circulation 2010, 121:2388-2397.
15. Consuegra-Sanchez L., Fredericks S., Kaski J.C. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 2000, 203:346-352.
16. Giguere Y., Charland M., Theriault S., Bujold E., Laroche M., Rousseau M., Lafond J., Forest J.C. Linking preeclampsia and cardiovascular disease later in life. Clin. Chem. Lab. Med. 2012, 50:985-993.
17. Noori M., Donald A.E., Angelakopoulou A., Hingorani A.D., Williams D.J. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010, 122:478-487.
18. Warrington J.P., George E.M., Palei A.C., Spradley F.T., Granger J.P. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension 2013, 62:666-673.
19. Girouard J., Giguère Y., Moutquin J.M., Forest J.C. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007, 49:1056-1062.
20. Wolf M., Hubel C.A., Lam C., Sampson M., Ecker J.L., Ness R.B., Rajakumar A., Daftary A., Shakir A.S.M., Seely E.W., Roberts J.M., Sukhatme S., Karumanchi A., Thadhani R. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J. Clin. Endocrinol. Met. 2004, 89:6239-6243.
21. Gaugler-Senden I.P.M., Tamsma J.T., van der Bent C., Kusters R., Steegers E.A.P., de Groot C.J.M. Angiogenic factors in women ten years after severe very early onset preeclampsia. PlosOne 2012, 7:e43637.
22. Evans C.S., Gooch L., Flotta D., Lykins D., Powers R.W., Landsittel D., Roberts J.M., Shroff S.G. Cardiovascular system during the postpartum state in women with a history of preeclampsia. Hypertension 2011, 58:57-62.
23. Costacou T., Bosnyak Z., harger G.F., Matkovic N., Silvers N., Orchard T.J. Postpartum adiponectine concentration insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances. Prev. Cardiol. 2008, 11:106-115.
24. Bonaca M.P., Scirica B.M., Sabatine M.S., Jarolim P., Mruphy S.A., Chamberlin J.S., Rhodes D.W., Southwick P.C., Braunwald E., Morrow D.A. Prospective evaluation of pregnancy-associated plasma protein-A and outcomes in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 2012, 60:332-338.
25. http://www.luminexcorp.com/Products/Assays.
26. Muris D.M., Houben A.J., Schram M.T., Stehouwer C.D. Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:3082-3094.
27. Krishnamoorthy S., Khoo C.W., Lim H.S., Lane D.A., Pignatelli P., Basili S., Violi F., Lip G.Y. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. Eur. J. Clin. Invest 2013, 43:1032-1038.
28. Dane B., Batmaz G., Dansuk R. First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies. Gynecol. Endocrinol. 2013, 29:592-595.
29. Lai J., Pinas A., Poon L.C., Agathokleous M., Nicolaides K.H. Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotropin at 30-33 weeks in the prediction of pre-eclampsia. Fetal Diagn Ther. 2013, 33:164-172.
30. Palei A.C.T., Granger J.P., Tanus-Santos J.E. Matrix metalloproteinases as drug targets in preeclampsia. Curr. Drug. Targets 2013, 14:325-334.
31. Iversen K.K., Teisner A.S., Teisner B., Kliem A., Thanninh P., Nielsen H., Clemmensen P., Grande P. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin. Biochem. 2009, 42:828-834.
32. Sniderman A.S., Williams K., Contois J.H., Monroe H.M., McQueen M.J., de Graaf J., Furberg C.D. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ. Cardiovasc. Qual. Outcomes 2011, 4:337-345.
33. Schaefer E.J., Lamon-Fava S., Cohn S.D., Schaefer M.M., Ordovas J.M., Castelli W.P., Wilson P.W. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res. 1994, 35:779-792.
34. Duvillard L., Dautin G., Florentin E., Petit J.M., Gambert P., Vergès B. Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study. J. Clin. Endocrinol. Metab. 2010, 95:2140-2146.
35. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., Albus C., Benlian P., Boysen G., Cifkova R., Deaton C., Ebrahim S., Fisher M., Germano G., Hobbs R., Hoes A., Karadeniz S., Mezzani A., Prescott E., Ryden L., Scherer M., Syvänne M., Scholte op Reimer W.J., Vrints C., Wood D., Zamorano J.L., Zannad F., European Association for Cardiovascular Prevention & Rehabilitation (EACPR), ESC Committee for Practice Guidelines (CPG) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012, 33:1635-1701. Erratum in: Eur Heart J 2012; 33:2126.